RELATIONSHIP BETWEEN BLOOD CHOLESTEROL AND INCREASED METABOLISM FROM DINITROPHENOL AND THYROID 1
Open accessAbstract
It has long been known that certain manifestations of hyperthyroidism follow directly upon the increased metabolic rate, but the causes of other changes in the disease are not so obvious.Dinitrophenol increases metabo- lism by a peripheral action in the tissues, and apparently has no other con- comitant actions in therapeutic doses (1 to 10); thus it is available for studying isolated effects of increased metabolism and determining the im- portance of the latter in thyrotoxicosis.Anxiety, palpitation, and tremor, which are commonly found in hyperthyroidism, are absent when the metabolism is correspondingly increased by dinitrophenol, but increased perspiration and sensations of warmth are present in both (7).The latter symptoms, therefore, are apparently due directly to the heightened metabolism.Another difference from thyroid or thyroxine (6) is absence of accelerated metamorphosis of tadpoles.The heightened metabolism caused by excess thyroid is associated with an in- creased pulse pressure, while that of dinitrophenol is not accompanied by an increased output, as judged from pulse pressure-pulse rate formulae.However, some change in output can be demonstrated in experimental ani- mals with metabolic rates beyond those seen clinically (8).Apparently, with dinitrophenol the tissues get their greater oxygen supply, at least partly, by increased deoxygenation of the blood.In our experience after dinitrophenol, and after dinitro-o-cresol (19), patients with severe degrees of hypothyroidism fail to get symptomatic relief even though the metabolic rate is restored to normal by these drugs.Thus, the ability to increase me- tabolism appears to be the only common action of dinitrophenol and thyroid so far studied.This paper deals with a blood-constituent which is quantitatively modi- fied in thyroid disease, namely, cholesterol.The concentration df blood cholesterol is usually raised in hypothyroidism, and lowered slightly in hyperthyroidism.Therefore, we have studied the changes in cholesterol after dinitrophenol medication to determine whether it varies with the meta- 1 Supported in part by a grant from the Rockefeller Fluid Research Fund of the
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Mitochondria are central to the regulation of energy expenditure, and targeting their activity has been a prospect for obesity therapies for decades.
“Mitochondria are central to the regulation of energy expenditure, and targeting their activity has been a prospect for obesity therapies for decades [47, 48], [49].”
From Regulation of obesity and insulin resistance by nitric oxide (2014) · cites this paper as [47]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
MODIFICATION OF BLOOR'S METHOD FOR THE DETERMINATION OF CHOLESTEROL IN WHOLE BLOOD OR BLOOD SERUM
Sackett, G. E. (1925) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)84961-4 · Cited by 190 · see citing works
Blood Cholesterol Values in Hyperthyroidism and Hypothyroidism — Their Significance
Mason, R. L., HUNT, H. M., & Hurxthal, L. M. (1930) · New England Journal of Medicine · doi:10.1056/nejm193012252032601 · Cited by 167 · see citing works
ACTIONS AND USES OF DINITROPHENOL
Cutting, W., MEHRTENS, H. G., & Tainter, M. L. (1933) · JAMA · doi:10.1001/jama.1933.02740280013006 · Cited by 138 · see citing works
USE OF DINITROPHENOL IN OBESITY AND RELATED CONDITIONS: A PROGRESS REPORT
TAINTER, M. L., STOCKTON, A. B., & CUTTING, W. C. (1933) · Journal of the American Medical Association · doi:10.1001/jama.1933.02740440032009 · Cited by 112 · see citing works
Self-citationEpstein, A. A. (1922) · Archives of Internal Medicine · doi:10.1001/archinte.1922.00110110034005 · Cited by 100 · see citing works
Introduction to Medical Biometry and Statistics.
H., A. B., & Pearl, R. (1931) · Journal Of The Royal Statistical Society · doi:10.2307/2342370 · Cited by 51 · see citing works
Hall, V. E., Field, J., Sahyun, M. R. V., Cutting, W., & Tainter, M. L. (1933) · American Journal of Physiology-Legacy Content · doi:10.1152/ajplegacy.1933.106.2.432 · Cited by 40 · see citing works
BLOOD CHOLESTEROL IN THYROID DISEASE
Hurxthal, L. M. (1933) · Archives of Internal Medicine · doi:10.1001/archinte.1933.00150200025002 · Cited by 35 · see citing works
Cutting, W., & Tainter, M. L. (1932) · Experimental Biology and Medicine · doi:10.3181/00379727-29-6315 · Cited by 31 · see citing works
FEBRILE, RESPIRATORY AND SOME OTHER ACTIONS OF DINITROPHENOL
Tainter, M. L., & Cutting, W. (1933) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)05999-3 · Cited by 26 · see citing works
METABOLIC ACTIONS OF DINITROPHENOL
Cutting, W., & Tainter, M. L. (1933) · JAMA · doi:10.1001/jama.1933.02740520009003 · Cited by 22 · see citing works
THE PLASMA FATS AND THE IODINE ABSORPTION CAPACITY OF THE FATTY ACIDS IN HYPERTHYROIDISM
Nicholls, E. G., & PERLZWEIG, W. A. (1928) · Journal of Clinical Investigation · doi:10.1172/jci100153 · Cited by 18 · see citing works
Comparative Effects of Dinitrophenol and Thyroxin on Tadpole Metamorphosis.
Cutting, C. C., & Tainter, M. L. (1933) · Experimental Biology and Medicine · doi:10.3181/00379727-31-7011c · Cited by 18 · see citing works
THE CLINICAL APPLICATIONS OF DINITRO-O-CRESOL
Dodds, E. C., & Robertson, J. D. (1933) · The Lancet · doi:10.1016/s0140-6736(00)90418-5 · Cited by 17 · see citing works
Tainter, M. L., & Cutting, W. (1933) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)06020-3 · Cited by 11 · see citing works
Relationship of Plasma Cholesterol and Basal Metabolism.
Gardner, J. A., & Gainsborough, H. (1929) · Anesthesia & Analgesia · doi:10.1213/00000539-192901000-00069 · Cited by 6 · see citing works
THE ADRENALIN TEST AND CHOLESTEROL DETERMINATION IN THE DIAGNOSIS OF BORDERLINE HYPERTHYROIDISM
Hinton, J. W. (1930) · The American Journal of the Medical Sciences · doi:10.1097/00000441-193011000-00013 · Cited by 4 · see citing works
Effects of Dinitrophenol on an Experimental Sarcoma of the White Rat.
Emge, L. A., Wulff, L., & Tainter, M. L. (1933) · Experimental Biology and Medicine · doi:10.3181/00379727-31-7035p · Cited by 4 · see citing works
THE RATE OF EXCRETION OF URINE IN SUBJECTS WITH DIFFERENT AMOUNTS OF RENAL TISSUE 1
Rytand, D. A. (1933) · Journal of Clinical Investigation · doi:10.1172/jci100567 · Cited by 2 · see citing works
Flagged first, then by citations
Research works printed but not linked: 1
- Tainter, M. L., Boyes, J. H., and DeEds, F., Actions of dinitrophenol in diabetic dogs. Arch. internat. de pharmacodyn. et de therap., 1933, 45, 235.
Cited by
Sorted by citations
Regulation of obesity and insulin resistance by nitric oxide
Sansbury, B. E., & Hill, B. G. (2014) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2014.05.016 · Cited by 274 · see citing works
“been a prospect for obesity therapies for decades [47–49].”
BackgroundThyroid hormone mimetics: potential applications in atherosclerosis, obesity and type 2 diabetes
Baxter, J. D., & Webb, P. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2830 · Cited by 253 · see citing works
THE MECHANISM RESPONSIBLE FOR THE ALTERED BLOOD CHOLESTEROL CONTENT IN DERANGED THYROID STATES*†
Rosenman, R. H., BYERS, S. O., & Friedman, M. (1952) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-12-10-1287 · Cited by 103 · see citing works
Use of Dinitrophenol in Nutritional Disorders: A Critical Survey of Clinical Results
Tainter, M. L., Cutting, W. C., & Stockton, A. B. (1934) · American Journal of Public Health and the Nations Health · doi:10.2105/ajph.24.10.1045 · Cited by 90 · see citing works
Salicylates and Thyroid Function. I. Depression of Thyroid Function
Austen, F., Rubini, M. E., Meroney, W. H., & Wolff, J. (1958) · Journal of Clinical Investigation · doi:10.1172/jci103703 · Cited by 82 · see citing works
Yuan, C., Zhang, X., Long, X., Jin, J., & Jin, R. (2019) · Lipids in Health and Disease · doi:10.1186/s12944-019-1096-2 · Cited by 67 · see citing works
Toxicological Profile for Dinitrophenols
(2002) · CRC Press eBooks · doi:10.1201/9781420061888_ch78 · Cited by 56 · see citing works
Malmros, H., & Swahn, B. (1953) · Acta Medica Scandinavica · doi:10.1111/j.0954-6820.1953.tb07030.x · Cited by 46 · see citing works
Effects of the Environment, Chemicals and Drugs on Thyroid Function
Sarne, D. (2016) · Cited by 38 · see citing works
Bruch, H. (1939) · American journal of diseases of children · doi:10.1001/archpedi.1939.01990100083009 · Cited by 37 · see citing works
Pharmacological Treatment of Obesity
Kabra, D. G., Kabra, U. D., Tschöp, M. H., & Hofmann, S. M. (2012) · Springer eBooks · doi:10.1007/978-1-4614-3492-4_14 · Cited by 32 · see citing works
Kim, D. N., Lee, K. T., Sherman, L. A., Milano, M. R., & Thomas, W. A. (1964) · Experimental and Molecular Pathology · doi:10.1016/0014-4800(64)90056-5 · Cited by 29 · see citing works
Evaluation of Drugs Active against Experimental Atherosclerosis
Hess, R. (1964) · Advances in lipid research · doi:10.1016/b978-1-4831-9938-2.50013-3 · Cited by 26 · see citing works
A Study of Dinitrophenol and Its Relation to Cataract Formation.
Horner, W. D. (1941) · Europe PMC (PubMed Central) · Cited by 25 · see citing works
CHOPRA, I. J., Solomon, D. H., TECO, G. N. C., & NGUYEN, A. H. (1980) · Endocrinology · doi:10.1210/endo-106-6-1728 · Cited by 24 · see citing works
METABOLIC EFFECTS OF THYROXINE ANALOGUES IN HUMAN MYXEDEMA*
Benua, R. S., Leeper, R. D., KUMAOKA, S., & Rawson, R. W. (1960) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1960.tb42829.x · Cited by 19 · see citing works
EFFECT OF TOTAL THYROIDECTOMY IN MAN
Schnitker, M. T. (1936) · Archives of Internal Medicine · doi:10.1001/archinte.1936.00170090022002 · Cited by 19 · see citing works
Hurxthal, L. M., & HUNT, H. M. (1935) · Annals of Internal Medicine · doi:10.7326/0003-4819-9-6-717 · Cited by 17 · see citing works
BLOOD CHOLESTEROL IN DISTURBANCES OF THE BASAL METABOLIC RATE
McGee, L. C. (1935) · Annals of Internal Medicine · doi:10.7326/0003-4819-9-6-728 · Cited by 13 · see citing works
Mode of Action of Cholesterol-Lowering Agents
CHIU, G. C. (1961) · Archives of Internal Medicine · doi:10.1001/archinte.1961.03620110057009 · Cited by 13 · see citing works
BLOOD LIPID PARTITION IN HYPOTHYROIDISM OF CHILDHOOD
Radwin, L. S. (1940) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/archpedi.1940.02000050104009 · Cited by 12 · see citing works
Bruger, M., & Hollander, V. P. (1951) · Annals of Internal Medicine · doi:10.7326/0003-4819-35-6-1260 · Cited by 9 · see citing works
Weiss, R. E., & Refetoff, S. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-18907-1.00078-0 · Cited by 8 · see citing works
Haas, H. T. A. (1939) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf01924822 · Cited by 8 · see citing works
Sachs, M. L. (1961) · Journal of Chronic Diseases · doi:10.1016/0021-9681(61)90017-0 · Cited by 8 · see citing works
Kim, D. N., Lee, K. T., & Thomas, W. A. (1965) · Experimental and Molecular Pathology · doi:10.1016/0014-4800(65)90039-0 · Cited by 6 · see citing works
The effect of thyrotropic hormone upon serum cholesterol
Pugsley, L. I. (1935) · Biochemical Journal · doi:10.1042/bj0290513 · Cited by 6 · see citing works
Oxidation of cholesterol by rat liver mitochondria: Effect of thyroactive compounds
Kritchevsky, D., Cottrell, M. C., & Tepper, S. A. (1962) · Journal of Cellular and Comparative Physiology · doi:10.1002/jcp.1030600112 · Cited by 6 · see citing works
Investigations of some Biochemical Changes Occurring during Treatment of Hyperthyroidism
Lundbaek, K. (1947) · Acta Medica Scandinavica · doi:10.1111/j.0954-6820.1947.tb13139.x · Cited by 5 · see citing works
The clinical significance of cholesterol
Muller, G. L. (1945) · The American Journal of Digestive Diseases · doi:10.1007/bf02998507 · Cited by 5 · see citing works
Die Wirkung des Quercitrins auf die durch Dinitrophenol verursachte Hyperthermie
Jeney, A., Ari, L., & Baranyai, P. (1938) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf01998839 · Cited by 5 · see citing works
Essential Hypercholesterolemia
SCHETTLER, G. F., Kahlke, W., & Schlierf, G. (1967) · Springer eBooks · doi:10.1007/978-3-642-87367-6_16 · Cited by 5 · see citing works
The disordered metabolisms in thyrotoxicosis and myxoedema.
Jd, R. (1949) · PubMed Central · Cited by 4 · see citing works
Seel, H. (1949) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf00244626 · Cited by 4 · see citing works
Fifteen years’ study of occult lymphocytosis in 280 hypercholesterolemia patients
Tuttle, E. (1950) · The American Journal of Digestive Diseases · doi:10.1007/bf03002551 · Cited by 3 · see citing works
Drugs Acting on Lipid Catabolism and Excretion
Preziosi, P. (1964) · Medicinal chemistry · doi:10.1016/b978-0-12-544952-6.50016-2 · Cited by 3 · see citing works
Diiodothyropropionic acid: WO2008106213
Raval, S. (2010) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543771003662636 · Cited by 2 · see citing works
Weiss, R. E., & Refetoff, S. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-5583-9.00077-0 · Cited by 2 · see citing works
Untersuchungen an den Lipoiden des menschlichen Blutserums bei Hyperthyreose
Schulze, G. (1953) · Verhandlungen der Deutschen Gesellschaft für Innere Medizin · doi:10.1007/978-3-642-53823-0_112 · Cited by 2 · see citing works
Westerlund, E. (1942) · Journal of Molecular Medicine · doi:10.1007/bf01775189 · Cited by 1 · see citing works
Medical Management of Coronary Artery Disease
Calesnick, B. (1963) · Angiology · doi:10.1177/000331976301400104 · Cited by 1 · see citing works
The anti-obesogenic effects of nitric oxide.
Sansbury, B. E. (2014) · doi:10.18297/etd/1262
Felt, V., & Vrbenský, V. (1964) · PubMed
Felt, V., & Vrbenský, V. (1964) · Research in Experimental Medicine · doi:10.1007/bf02045221
Author Index, v.1-17: A-Isaacs
(1940) · Journal of Clinical Investigation · doi:10.1172/jci101100
Disorders of internal gland secretion in children
TALBOT, F. B., & Talbot, N. B. (1938) · The Journal of Pediatrics · doi:10.1016/s0022-3476(38)80014-7
(1959) · Elsevier eBooks · doi:10.1016/b978-0-08-009203-4.50017-3
Das Lipoidsyndrom und die essentielle Hyperlipämie
Schulze, G. (1958) · Springer eBooks · doi:10.1007/978-3-642-94724-7_2
- Authors
- Cutting, W. C., Rytand, D. A., & Tainter, M. L.
- Affiliations
- Stanford Medicine (US)
- Venue
- Journal of Clinical Investigation
- Published
- 1934-07-01
- Volume
- 13
- Issue
- 4
- Pages
- 547-552
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC436012
- OpenAlex
- W2056764648
- Cited by
- 48
- References
- 19
- Citations by year
- 2019: 1 · 2016: 1 · 2015: 1 · 2014: 2 · 2012: 1
- FWCI
- 3.79
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
- Health Sciences › Medicine › Surgery › Thyroid and Parathyroid Surgery
- Health Sciences › Medicine › Pathology and Forensic Medicine › Ophthalmology and Eye Disorders
- Keywords
- serum cholesterol, dinitrophenol, hyperthyroidism, hypothyroidism, thyrotoxicosis, thyroid dysfunction, dinitro-o-cresol, pulse pressure, oxygen supply
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review